MeiraGTx
Price & Volume
Stats
See more52W Range | $3.85-$7.79 |
Market Cap | $570.5M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $13.9M |
Revenue Growth (YoY) | 113.8% |
Gross Profit (12 Mos) | $1.9M |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • 2 days ago
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
Yahoo Finance • last month
MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations
Yahoo Finance • last year
The past three years for MeiraGTx Holdings (NASDAQ:MGTX) investors has not been profitable
Yahoo Finance • last year
MeiraGTx to Participate in Upcoming Investor Conferences
About
CEO | Dr. Alexandria Forbes Ph.D. |
CFO | Mr. Richard Brian Giroux B.A. |
Address | 450 East 29th Street, New York, NY, United States, 10016 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 389 |
